DK1365808T3 - Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743 - Google Patents

Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743

Info

Publication number: DK1365808T3
Authority: DK; Denmark
Prior art keywords: ecteinascidin; compositions; treatment containing; antitumor treatment; antitumor
Prior art date: 2000-11-06

Application number

DK01980710.6T

Other languages

English (en)

Inventor

Naoto Takahashi

Maurizio D'incalci

Rafaella Giavazzi

Andreas Gescher

Steve Weitman

Glynn Thomas Faicloth

Original Assignee

Pharma Mar Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-06

Filing date

2001-11-06

Publication date

2011-05-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27399908&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1365808(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-11-06 Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa

2011-05-16 Application granted granted Critical

2011-05-16 Publication of DK1365808T3 publication Critical patent/DK1365808T3/da

Links

XXPXYPLPSDPERN-UHFFFAOYSA-N Ecteinascidin 743 Natural products COc1cc2C(NCCc2cc1O)C(=O)OCC3N4C(O)C5Cc6cc(C)c(OC)c(O)c6C(C4C(S)c7c(OC(=O)C)c(C)c8OCOc8c37)N5C XXPXYPLPSDPERN-UHFFFAOYSA-N 0.000 title abstract 3
PKVRCIRHQMSYJX-AIFWHQITSA-N trabectedin Chemical compound C([C@@]1(C(OC2)=O)NCCC3=C1C=C(C(=C3)O)OC)S[C@@H]1C3=C(OC(C)=O)C(C)=C4OCOC4=C3[C@H]2N2[C@@H](O)[C@H](CC=3C4=C(O)C(OC)=C(C)C=3)N(C)[C@H]4[C@@H]21 PKVRCIRHQMSYJX-AIFWHQITSA-N 0.000 title abstract 3
229960000977 trabectedin Drugs 0.000 title abstract 3
230000000259 anti-tumor effect Effects 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000003814 drug Substances 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
238000002648 combination therapy Methods 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

DK01980710.6T 2000-11-06 2001-11-06 Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743 DK1365808T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US24623300P	2000-11-06	2000-11-06
US24809500P	2000-11-13	2000-11-13
US34598201P	2001-10-19	2001-10-19
PCT/GB2001/004902 WO2002036135A2 (en)	2000-11-06	2001-11-06	Compositions for antitumour treatment containing ecteinascidin 743

Publications (1)

Publication Number	Publication Date
DK1365808T3 true DK1365808T3 (da)	2011-05-16

Family

ID=27399908

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01980710.6T DK1365808T3 (da)	2000-11-06	2001-11-06	Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743

Country Status (25)

Country	Link
US (3)	US20040108086A1 (da)
EP (1)	EP1365808B1 (da)
JP (2)	JP4391083B2 (da)
KR (1)	KR100718946B1 (da)
CN (1)	CN100374162C (da)
AT (1)	ATE495793T1 (da)
AU (2)	AU1249902A (da)
BG (1)	BG107843A (da)
BR (1)	BR0115162A (da)
CA (1)	CA2428160C (da)
CY (1)	CY1112361T1 (da)
CZ (1)	CZ20031327A3 (da)
DE (1)	DE60143911D1 (da)
DK (1)	DK1365808T3 (da)
EA (1)	EA005564B1 (da)
HK (1)	HK1060067A1 (da)
HU (1)	HUP0400648A3 (da)
IL (1)	IL155781A0 (da)
MX (1)	MXPA03003975A (da)
NO (1)	NO329981B1 (da)
NZ (1)	NZ525730A (da)
PL (1)	PL361389A1 (da)
PT (1)	PT1365808E (da)
SK (1)	SK287901B6 (da)
WO (1)	WO2002036135A2 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY164077A (en)	1999-05-13	2017-11-30	Pharma Mar Sa	Compositions and uses of et743 for treating cancer
MXPA02011319A (es) *	2000-05-15	2003-06-06	Pharma Mar Sa	Analogos antitumorales de ecteinascidina 743.
AU1249902A (en) *	2000-11-06	2002-05-15	Pharma Mar Sa	Effective antitumour treatments
GB0117402D0 (en) *	2001-07-17	2001-09-05	Pharma Mar Sa	New antitumoral derivatives of et-743
HUP0401903A3 (en) *	2001-10-19	2008-07-28	Pharma Mar	Improved use of et-743 in cancer thereapy
GB0202544D0 (en) *	2002-02-04	2002-03-20	Pharma Mar Sa	The synthesis of naturally occuring ecteinascidins and related compounds
US20050043233A1 (en) *	2003-04-29	2005-02-24	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
GB0312407D0 (en) *	2003-05-29	2003-07-02	Pharma Mar Sau	Treatment
GB0324201D0 (en) *	2003-10-15	2003-11-19	Pharma Mar Sau	Improved antitumoral combinations
US7622458B2 (en) *	2003-11-13	2009-11-24	Pharma Mar, S.A.U.	Combination of ET-743 and a 5-fluorouracil pro-drug for cancer treatment
JP2007511509A (ja) *	2003-11-14	2007-05-10	ファルマ・マール・ソシエダード・アノニマ	Ｅｔ−７４３およびパクリタキセルの使用を含むガンの併用療法
GB0326486D0 (en) *	2003-11-14	2003-12-17	Pharma Mar Sau	Combination treatment
JP2008505862A (ja) *	2004-07-09	2008-02-28	ファルマ、マール、ソシエダード、アノニマ	予後分子マーカー
US20080242670A2 (en) *	2004-09-29	2008-10-02	Pharma Mar S.A., Sociedad Unipersonal	Anti-Inflammatory Agents
AU2005298364B2 (en) *	2004-10-26	2009-03-26	Ortho Biotech Products L.P.	Pegylated Liposomal Doxorubicin in combination with Ecteinescidin 743
NZ554761A (en)	2004-10-29	2010-01-29	Pharma Mar Sa	Formulations comprising ecteinascidin and a disaccharide
GB0522082D0 (en)	2005-10-31	2005-12-07	Pharma Mar Sa	Formulations
CA2630900A1 (en) *	2005-11-25	2007-05-31	University Of Medicine And Dentistry Of New Jersey	Use of parp-1 inhibitors
CA2703026A1 (en) *	2007-10-19	2009-04-23	Rafael Rosell Costa	Prognostic molecular markers for et-743 treatment
RS60236B1 (sr) *	2010-11-12	2020-06-30	Pharma Mar Sa	Kombinovana terapija sa inhibitorom topoizomeraze
GB201217439D0 (en) *	2012-09-28	2012-11-14	Topotarget As	Combination therapy
WO2014165818A2 (en)	2013-04-05	2014-10-09	T Cell Therapeutics, Inc.	Compositions and methods for preventing and treating prostate cancer
JOP20190254A1 (ar)	2017-04-27	2019-10-27	Pharma Mar Sa	مركبات مضادة للأورام
US10537585B2 (en)	2017-12-18	2020-01-21	Dexcel Pharma Technologies Ltd.	Compositions comprising dexamethasone
CN109276719A (zh) *	2018-11-01	2019-01-29	中山万汉制药有限公司	含有奥利司他纳米粒与蛋白激酶抑制剂的组合物

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5089273A (en) *	1986-06-09	1992-02-18	Board Of Trustees Of The University Of Illinois	Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5149804A (en) *	1990-11-30	1992-09-22	The Board Of Trustees Of The University Of Illinois	Ecteinascidins 736 and 722
US5256663A (en) *	1986-06-09	1993-10-26	The Board Of Trustees Of The University Of Illinois	Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
DE3635711A1 (de) *	1986-10-21	1988-04-28	Knoll Ag	5-nitrobenzo(de)isochinolin-1,3-dione, ihre herstellung und verwendung
FR2697752B1 (fr) *	1992-11-10	1995-04-14	Rhone Poulenc Rorer Sa	Compositions antitumorales contenant des dérivés du taxane.
US5478932A (en) *	1993-12-02	1995-12-26	The Board Of Trustees Of The University Of Illinois	Ecteinascidins
US20040059112A1 (en) *	1994-02-18	2004-03-25	Rinehart Kenneth L.	Ecteinascidins
GB9508195D0 (en) *	1995-04-20	1995-06-07	Univ British Columbia	Novel biologically active compounds and compositions,their use and derivation
US5721362A (en) *	1996-09-18	1998-02-24	President And Fellows Of Harvard College	Process for producing ecteinascidin compounds
US5985876A (en) *	1997-04-15	1999-11-16	Univ Illinois	Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
EP0983082A1 (en) *	1997-05-21	2000-03-08	Genentech, Inc.	Novel administration of thrombopoietin
HUP0104273A3 (en) *	1998-04-06	2003-12-29	Univ Illinois	Semi-synthetic ecteinascidins and pharmaceutical compositions containing them
ATE289810T1 (de) *	1998-05-11	2005-03-15	Pharma Mar Sa	Ecteinascidinderivate
JP2000081438A (ja) *	1998-06-25	2000-03-21	Sekisui Chem Co Ltd	被験者の癌化学療法による免疫機能低下の測定方法
US6124292A (en) *	1998-09-30	2000-09-26	President And Fellows Of Harvard College	Synthetic analogs of ecteinascidin-743
MY164077A (en) *	1999-05-13	2017-11-30	Pharma Mar Sa	Compositions and uses of et743 for treating cancer
AR035842A1 (es) *	1999-05-14	2004-07-21	Pharma Mar Sa	Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
US7247892B2 (en) *	2000-04-24	2007-07-24	Taylor Geoff W	Imaging array utilizing thyristor-based pixel elements
US7420051B2 (en) *	2000-05-15	2008-09-02	Pharma Mar, S.A.	Synthetic process for the manufacture of an ecteinaschidin compound
MXPA02011319A (es) *	2000-05-15	2003-06-06	Pharma Mar Sa	Analogos antitumorales de ecteinascidina 743.
JP2004506430A (ja) *	2000-08-11	2004-03-04	シティ・オブ・ホープ	Ｓｘｒによるトランス活性化の抗新生物剤ｅｔ−７４３による阻害
AU1249902A (en) *	2000-11-06	2002-05-15	Pharma Mar Sa	Effective antitumour treatments
PL363967A1 (en) *	2001-03-06	2004-11-29	Bristol-Myers Squibb Company	Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
JP4391038B2 (ja) *	2001-05-10	2009-12-24	パナソニック株式会社	電気炊飯器
HUP0401903A3 (en) *	2001-10-19	2008-07-28	Pharma Mar	Improved use of et-743 in cancer thereapy
US20040019027A1 (en) *	2002-04-12	2004-01-29	Barry Forman	Method of treating cerebrotendinous xanthomatosis
GB0312407D0 (en) *	2003-05-29	2003-07-02	Pharma Mar Sau	Treatment
GB0324201D0 (en) *	2003-10-15	2003-11-19	Pharma Mar Sau	Improved antitumoral combinations
US7622458B2 (en) *	2003-11-13	2009-11-24	Pharma Mar, S.A.U.	Combination of ET-743 and a 5-fluorouracil pro-drug for cancer treatment
GB0326486D0 (en) *	2003-11-14	2003-12-17	Pharma Mar Sau	Combination treatment
JP2007511509A (ja) *	2003-11-14	2007-05-10	ファルマ・マール・ソシエダード・アノニマ	Ｅｔ−７４３およびパクリタキセルの使用を含むガンの併用療法
JP2008505862A (ja) *	2004-07-09	2008-02-28	ファルマ、マール、ソシエダード、アノニマ	予後分子マーカー
US20080242670A2 (en) *	2004-09-29	2008-10-02	Pharma Mar S.A., Sociedad Unipersonal	Anti-Inflammatory Agents
AU2005298364B2 (en) *	2004-10-26	2009-03-26	Ortho Biotech Products L.P.	Pegylated Liposomal Doxorubicin in combination with Ecteinescidin 743
NZ554761A (en) *	2004-10-29	2010-01-29	Pharma Mar Sa	Formulations comprising ecteinascidin and a disaccharide
CA2630900A1 (en) *	2005-11-25	2007-05-31	University Of Medicine And Dentistry Of New Jersey	Use of parp-1 inhibitors
CA2652035A1 (en) *	2006-05-12	2007-11-22	Pharma Mar, S.A.	Anticancer treatments

2001
- 2001-11-06 AU AU1249902A patent/AU1249902A/xx active Pending
- 2001-11-06 WO PCT/GB2001/004902 patent/WO2002036135A2/en active IP Right Grant
- 2001-11-06 SK SK549-2003A patent/SK287901B6/sk not_active IP Right Cessation
- 2001-11-06 CA CA002428160A patent/CA2428160C/en not_active Expired - Fee Related
- 2001-11-06 HU HU0400648A patent/HUP0400648A3/hu unknown
- 2001-11-06 BR BR0115162-2A patent/BR0115162A/pt not_active IP Right Cessation
- 2001-11-06 CN CNB018218032A patent/CN100374162C/zh not_active Expired - Fee Related
- 2001-11-06 PL PL01361389A patent/PL361389A1/xx not_active Application Discontinuation
- 2001-11-06 CZ CZ20031327A patent/CZ20031327A3/cs unknown
- 2001-11-06 PT PT01980710T patent/PT1365808E/pt unknown
- 2001-11-06 DE DE60143911T patent/DE60143911D1/de not_active Expired - Lifetime
- 2001-11-06 AT AT01980710T patent/ATE495793T1/de active
- 2001-11-06 DK DK01980710.6T patent/DK1365808T3/da active
- 2001-11-06 AU AU2002212499A patent/AU2002212499B2/en not_active Ceased
- 2001-11-06 US US10/416,086 patent/US20040108086A1/en not_active Abandoned
- 2001-11-06 MX MXPA03003975A patent/MXPA03003975A/es active IP Right Grant
- 2001-11-06 NZ NZ525730A patent/NZ525730A/xx not_active IP Right Cessation
- 2001-11-06 JP JP2002538946A patent/JP4391083B2/ja not_active Expired - Fee Related
- 2001-11-06 KR KR1020037006228A patent/KR100718946B1/ko not_active IP Right Cessation
- 2001-11-06 IL IL15578101A patent/IL155781A0/xx unknown
- 2001-11-06 EA EA200300544A patent/EA005564B1/ru not_active IP Right Cessation
- 2001-11-06 EP EP01980710A patent/EP1365808B1/en not_active Revoked
2003
- 2003-05-06 NO NO20032027A patent/NO329981B1/no not_active IP Right Cessation
- 2003-05-23 BG BG107843A patent/BG107843A/bg unknown
2004
- 2004-05-04 HK HK04103120.3A patent/HK1060067A1/xx not_active IP Right Cessation
2009
- 2009-02-27 JP JP2009046557A patent/JP2009114212A/ja active Pending
- 2009-09-02 US US12/552,347 patent/US20090324744A1/en not_active Abandoned
2011
- 2011-04-18 CY CY20111100397T patent/CY1112361T1/el unknown
- 2011-12-30 US US13/341,262 patent/US20120107417A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BG107843A (bg)	2004-06-30
SK5492003A3 (en)	2004-03-02
CA2428160C (en)	2009-10-13
CA2428160A1 (en)	2002-05-10
US20090324744A1 (en)	2009-12-31
WO2002036135A2 (en)	2002-05-10
HK1060067A1 (en)	2004-07-30
EA005564B1 (ru)	2005-04-28
HUP0400648A3 (en)	2012-09-28
NO20032027L (no)	2003-07-04
PL361389A1 (en)	2004-10-04
BR0115162A (pt)	2003-10-21
EA200300544A1 (ru)	2003-08-28
CY1112361T1 (el)	2015-12-09
EP1365808A2 (en)	2003-12-03
CN1486193A (zh)	2004-03-31
JP2009114212A (ja)	2009-05-28
AU1249902A (en)	2002-05-15
ATE495793T1 (de)	2011-02-15
MXPA03003975A (es)	2004-02-12
WO2002036135A3 (en)	2003-04-10
NZ525730A (en)	2004-12-24
HUP0400648A2 (hu)	2004-06-28
US20040108086A1 (en)	2004-06-10
EP1365808B1 (en)	2011-01-19
CN100374162C (zh)	2008-03-12
NO20032027D0 (no)	2003-05-06
PT1365808E (pt)	2011-04-08
US20120107417A1 (en)	2012-05-03
KR100718946B1 (ko)	2007-05-16
IL155781A0 (en)	2003-12-23
JP2004517056A (ja)	2004-06-10
JP4391083B2 (ja)	2009-12-24
AU2002212499B2 (en)	2006-11-02
NO329981B1 (no)	2011-01-31
SK287901B6 (sk)	2012-03-02
DE60143911D1 (de)	2011-03-03
KR20030048127A (ko)	2003-06-18
CZ20031327A3 (cs)	2003-11-12

Publication	Publication Date	Title
DK1365808T3 (da)	2011-05-16	Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743
GEP20063799B (en)	2006-04-25	Tropane derivatives useful in therapy
TR200002786T2 (tr)	2001-01-22	Meloksikam için yeni galenik bir formülasyon.
BR0211228A (pt)	2004-08-10	Composto, composição farmacêutica e seus usos
CY1112753T1 (el)	2016-02-10	Θεραπευτικη αγωγη καρκινων του ανθρωπινου σωματος με τη χρηση toy ετ743
SE0001899D0 (sv)	2000-05-22	New compounds
DE60030741D1 (de)	2006-10-26	Chinazoline verbindungen als heilmittel
DE69925133D1 (de)	2005-06-09	Pyrrolobenzodiazepine
MXPA04003674A (es)	2004-07-23	Uso mejorado de compuesto antitumoral en terapia de cancer.
SE9802208D0 (sv)	1998-06-22	Novel compounds
ATE243196T1 (de)	2003-07-15	Piperidine und pyrrolidine
EE05241B1 (et)	2009-12-15	Distamtsiini a-halogenoakrlolderivaadi kasutamine
MXPA02012911A (es)	2004-07-30	Compuestos de rutenio (ii) para el uso en terapia del cancer.
GEP201606538B (en)	2016-09-12	Preoperative treatment of post operative pain
ATE233745T1 (de)	2003-03-15	Arzneistoffe
SE0004827D0 (sv)	2000-12-22	Therapeutic compounds
SE0000303D0 (sv)	2000-01-31	Novel compounds
GEP20043225B (en)	2004-04-26	1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
AR109456A2 (es)	2018-12-12	Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación
EP1374873B8 (en)	2005-06-29	The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy
ATE371446T1 (de)	2007-09-15	Zusammensetzungen zur verhinderung der adhäsion
UY27376A1 (es)	2003-02-28	Formulación de medicamento que contiene un antagonista de ltb4
DE60303131D1 (de)	2006-03-30	Synergistische wechselwirkung von abacavir und alovudin
ES2093515T3 (es)	1996-12-16	Aplicacion del riluzol como radio-restaurador.